Advanced Oncotherapy strikes China deal and raises £37m

Sean Farrell WebFG News | 07 Dec, 2017 09:55 | | |

ep cancerpulmon 20170530143102
  • 46.45
  • -0.11%-0.05
  • Max: 47.99
  • Min: 45.00
  • Volume: 28,436
  • MM 200 : n/a
14:05 15/12/17
  • 7,484.59
  • -0.72%-54.53
  • Max: 7,541.28
  • Min: 7,444.99
  • Volume: 0
  • MM 200 : n/a
16:05 15/12/17
  • 1,016.25
  • 0.14%1.46
  • Max: 1,016.55
  • Min: 1,013.24
  • Volume: 0
  • MM 200 : n/a
16:05 15/12/17
  • 0.00
  • 0.00%0.00
  • Max: n/a
  • Min: n/a
  • Volume: n/a
  • MM 200 : n/a
17:17 25/09/06

Advanced Oncotherapy shares surged after the cancer therapy specialist announced a distribution agreement for Greater China and South Korea and more than £37m in new funding.

The company said Yantai CIPU Medical Technology, a Chinese investor in the health industry, agreed to pay £16.5m to market and sell its LIGHT proton accelerator system.

Yantai will also buy 45m shares in Advanced Oncotherapy at 30p each, raising £13.5m. Other investors, including board members and debt holders will acquire shares on the same basis for a further £7.4m. The total funds raised will be £37.4m.

The shares had jumped 66% to 54.75p by 09:26 GMT on Thursday.

Advanced Oncotherapy develops proton treatments for cancer, which target a cancerous tumour more effectively than traditional radiation treatments with less damage to other parts of the body. LIGHT is the company’s latest proton accelerator, which it says is cheaper, more precise and smaller than previous versions.

Nicolas Serandour, Advanced Oncotherapy’s chief executive, said: "I am delighted that we have been able to conclude deals to provide shareholders not only with the security of longer-term financing, but which also introduce a new experienced strategic investor with strong distribution capacity and already established commercial interest in Asia, particularly in one of our key target markets, China.

Yantai, owned by the wealthy Han family, has identified eleven potential sites for installing LIGHT. The companies are aiming for three installations over the next four years and financing of 10 more. Yantai’s Zhang RenHua and Chunlin Han will join Advanced Oncotherapy’s board.

More news

16:06 Airbus chief executive to step down in board shake-up

The chief executive of French planemaker Airbus will step down from his position in 2019 as the company announced a major shake-up of its management team.

16:06 FTSE 250 movers: TalkTalk rises but Serco gives back gains

London’s FTSE 250 was up 0.1% to 20,023.23 in afternoon trade on Friday as the Christmas lull kicked in.

16:05 US industrial production rises slightly less than expected in November

Industrial production in the States rose slightly less quickly than expected last month, despite higher output of business equipment and materials.

16:03 Strategic Minerals renegotiates acquisition of Leigh Creek Copper Mine

Diversified mineral production and development company Strategic Minerals announced on Friday that, after the successful completion of technical and financial due diligence on the Leigh Creek Copper Mine company, it has agreed to continue with the acquisition on renegotiated terms.

15:54 FTSE 100 movers: Sky jumps but retailers retreat on H&M sales

London’s FTSE 100 was up 0.3% to 7,469.23 in quiet afternoon trade on Friday.

15:49 Gfinity partners with Microsoft for next Halo World Championship

International esports entertainment group Gfinity has been named as a preferred event partner to Microsoft for the forthcoming ‘Halo World Championship 2018’ for the next season, it announced on Friday.

15:46 Hutchison Chi-Med begins fruquintinib trial in US

Hutchison China MediTech, known as Chi-Med, has initiated the United States Phase I bridging clinical trial of fruquintinib, it announced on Friday.

14:50 Ceres Power upbeat ahead of half-year point

Solid oxide fuel cell technology developer Ceres Power Holdings updated the market on its trading ahead of the end of the six month period to 31 December on Friday.

14:46 Conviviality offers failed P&H £25m for 109 stores

Independent alcohol wholesaler and distributor of alcohol and impulse products Conviviality announced on Friday that its wholly-owned subsidiary Bargain Booze has offered to acquire the business and assets of 109 convenience stores, and the rights as franchisor of a further 18 franchisee-operated stores trading under the fascia 'Central Convenience'.

14:43 Nektan's Respin signs deal with Seven Feathers Casino

Respin, a wholly-owned subsidiary of Nektan, has reached an agreement with Seven Feathers Casino Resort in Oregon.